Tesamorelin

HCID 16137828CAS 218949-48-5

Completing data — usually done within a minute

Substructure search Find similar structures

Basic information

Standard SMILES: CC/C=C/CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)CC)C(C)C)[C@@H](C)O)[C@@H](C)CC
InChIKey: QBEPNUQJQWDYKU-BMGKTWPMSA-N
Molecular formula: C221H366N72O67S
Average molar mass: 5,135.863 g/mol
Monoisotopic mass: 5,132.71664025

Names & identifiers

Preferred name: Tesamorelin
English name: Tesamorelin
Molecular formula: C221H366N72O67S
Molecular weight: 5135.86

Names & synonyms

TesamorelinAdipotide/FTTPtesamorelTesamorelin 5mg/10mg/20mgTSM2D06655TirelinTimorelinTesamoreli APITesamorelin 8866

Database identifiers

CAS: 218949-48-5
PubChem CID: 16137828
DTXSID: DTXSID00583207

Properties

Physicochemical properties

storage temp.: 2 · 2-8°C Refrigerator
FDA UNII: 94 M5EEO · MQG94M5EEO

Chemistry & industry

Applications · 2 items

DescriptionTesamorelin (usan) consists of the 44 amino acid sequence of human growth hormone releasing factor (GRF), with a 3-hexenoyl group attached to its tyrosine N-terminal residue. It is a new growth hormone releasing factor analogue, which can not only restore normal growth hormone secretion in the body, but also reduce the increased visceral adipose tissue (VAT), improve blood lipid abnormalities and quality of life, and maintain glucose homeostasis in the body.

UsesTesamorelin (usan) is indicated for the treatment of excess abdominal fat in HIV-infected patients with lipodystrophy and is not recommended for weight loss.

Suppliers50 total

上海沛灵生物科技有限公司13127581762 13127581762 · [email protected]

Ningbo Qingteng Plastic Cost.,Ltd.+86-15028138352 +86-19322619905 · [email protected]

LIDE PHARMACEUTICALS LIMITED+852-55945652 · [email protected]

深圳市铭康生物技术有限公司18682083212 · [email protected]

曼顿生物科技（深圳）有限公司+86-75589664337 +86-15112661142 · [email protected]

Additional notes

DefinitionFDA Pharm Classes: Tesamorelin is a Growth Hormone Releasing Factor Analog. The physiologic effect of tesamorelin is by means of Increased GHRH Activity.

Related reactions

0 records

New reaction record

No reaction records under the current filter.

Linked notes

Loading…